A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency-Reference-Cited by-同舟云学术

A Real-World Study of Recombinant Human Growth Hormone in the Treatment of Idiopathic Short Stature and Growth Hormone Deficiency

Published:2022-03 Issue: Volume:Volume 18 Page:113-124
ISSN:1178-203X
Container-title:Therapeutics and Clinical Risk Management
language:en
Short-container-title:TCRM

Author:

Gou Peng,Cheng Xinran,Leng Jie,Su Na

Publisher

Informa UK Limited

Subject

Chemical Health and Safety,Pharmacology (medical),General Pharmacology, Toxicology and Pharmaceutics,Safety Research,General Medicine

Reference32 articles.

1. Recent advances in growth hormone signaling

2. Minireview: Mechanisms of Growth Hormone-Mediated Gene Regulation

3. Growth Hormone, Insulin-Like Growth Factors, and the Skeleton

4. Action of GH on skeletal muscle function: molecular and metabolic mechanisms

5. Subspecialty Group of Endocrinologic, Hereditary and Metabolic Diseases, Society of Pediatrics, Chinese Medical Association The Editorial Board, Chinese Journal of Pediatrics. Recommendations for the clinical use of recombinant human growth hormone in children. Zhonghua Er Ke Za Zhi. 2013;51:426–432.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. BMI z-score as a prognostic factor for height velocity in children treated with recombinant human growth hormone due to idiopathic growth hormone deficiency;Endocrine;2024-08-06

2. Key elements of Korean medicine treatment for idiopathic short-stature: A qualitative SWOT analysis based on Korean medicine doctors’ views;Medicine;2024-07-26

3. Therapeutic efficacy of recombinant human growth hormone in children with different etiologies of dwarfism from a pharmacoeconomic point of view;Medicine;2024-06-21

4. Comprehensive analysis of prohibited substances and methods in sports: Unveiling trends, pharmacokinetics, and WADA evolution;Environmental Toxicology and Pharmacology;2024-06